Overview

Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Periostat(R), Doxycycline Hyclate 20 mg Tablets, taken twice daily is effective in reducing the red and white heads and overall redness associated with rosacea.
Phase:
Phase 3
Details
Lead Sponsor:
CollaGenex Pharmaceuticals
Treatments:
Doxycycline